Literature DB >> 15510600

Radiofrequency Heat Ablation and Vertebroplasty in the treatment of neoplastic vertebral body fractures.

Salvatore Masala1, Mario Roselli, Francesco Massari, Roberto Fiori, Antonio Ursone, Emanuela Fossile, Anastasia Laudisi, Giovanni Simonetti.   

Abstract

BACKGROUND: Metastatic cancer is the most common malignant disease of the skeletal system. Traditionally, conventional fractionated external beam radiotherapy has been the treatment of choice. Recently, minimally invasive surgical techniques (MISS) have been added to the therapeutic armamentarium. The purpose of our study was to assess the effectiveness and safety of Radiofrequency Heat Ablation and Vertebroplasty in the treatment of neoplastic Vertebral Compressive Fractures (VCF). The aim of radiofrequency heat ablation is to destroy the tumor tissue before stabilizing the vertebra through the intrasomatic injection of cement. PATIENTS AND METHODS: We treated patients with unremitting pain over spine, in absence of symptomatic spinal cord or roots compression and refractory to conventional therapeutic options such as radiation therapy, chemotherapy, surgery and use of analgesics.
RESULTS: The method demonstrated swift pain relief associated with an evident augmentation in the weight-bearing resistance.
CONCLUSION: The association of Radiofrequency Heat Ablation and Vertebroplasty is an effective, simple and safe treatment of vertebral collapse consequent to metastases.

Entities:  

Mesh:

Year:  2004        PMID: 15510600

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  20 in total

1.  Radiofrequency sinus excision: better alternative to marsupialization technique in sacrococcygeal pilonidal sinus disease.

Authors:  Pravin J Gupta
Journal:  J Natl Med Assoc       Date:  2005-07       Impact factor: 1.798

Review 2.  [Vertebroplasty in the treatment of back pain].

Authors:  C G Trumm; T F Jakobs; C J Zech; C Weber; M F Reiser; R-T Hoffmann
Journal:  Radiologe       Date:  2006-06       Impact factor: 0.635

Review 3.  Current trends in mini-invasive management of spine metastases.

Authors:  Gianluigi Guarnieri; Roberto Izzo; Mario Muto
Journal:  Interv Neuroradiol       Date:  2015-05-11       Impact factor: 1.610

4.  Combined use of percutaneous cryoablation and vertebroplasty with 3D rotational angiograph in treatment of single vertebral metastasis: comparison with vertebroplasty.

Authors:  S Masala; M Chiocchi; A Taglieri; A Bindi; M Nezzo; D De Vivo; G Simonetti
Journal:  Neuroradiology       Date:  2012-09-27       Impact factor: 2.804

5.  New approach for treatment of vertebral metastases using intensity-modulated radiotherapy.

Authors:  Toshihiko Inoue; Ryoong-Jin Oh; Hiroya Shiomi
Journal:  Strahlenther Onkol       Date:  2011-01-21       Impact factor: 3.621

Review 6.  Metastatic spinal lesions: state-of-the-art treatment options and future trends.

Authors:  B A Georgy
Journal:  AJNR Am J Neuroradiol       Date:  2008-06-19       Impact factor: 3.825

7.  Percutaneous vertebroplasty: the follow-up.

Authors:  S Barbero; I Casorzo; M Durando; G Mattone; C Tappero; C Venturi; G Gandini
Journal:  Radiol Med       Date:  2008-02-25       Impact factor: 3.469

Review 8.  Cancer concepts and principles: primer for the interventional oncologist-part II.

Authors:  Ryan Hickey; Michael Vouche; Daniel Y Sze; Elias Hohlastos; Jeremy Collins; Todd Schirmang; Khairuddin Memon; Robert K Ryu; Kent Sato; Richard Chen; Ramona Gupta; Scott Resnick; James Carr; Howard B Chrisman; Albert A Nemcek; Robert L Vogelzang; Robert J Lewandowski; Riad Salem
Journal:  J Vasc Interv Radiol       Date:  2013-06-28       Impact factor: 3.464

Review 9.  Vertebral Augmentation Involving Vertebroplasty or Kyphoplasty for Cancer-Related Vertebral Compression Fractures: A Systematic Review.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2016-05-01

10.  Occurrence of malignant vertebral fractures in an emergency room setting.

Authors:  Ruben Dammers; Henk W C Bijvoet; Maarten J Driesse; Cees C J Avezaat
Journal:  Emerg Med J       Date:  2007-10       Impact factor: 2.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.